Literature DB >> 15857597

Breast cancer: steroid receptors and other prognostic indicators.

Saira Fatima1, Naveen Faridi, Shafique Gill.   

Abstract

OBJECTIVE: To correlate hormone receptor status in breast cancer with patient's age, tumor size, type, grade and lymph node metastasis.
DESIGN: A descriptive study. PLACE AND DURATION OF STUDY: Department of Histopathology, Liaquat National Postgraduate Medical Center, Karachi, from January 2002 to March 2003. PATIENTS AND METHODS: One hundred and fifty patients of breast cancer were studied. Estrogen and progesterone receptor status was evaluated by immunohistochemistry. This was correlated with patients' age, tumor size, type, grade and lymph node status.
RESULTS: Out of 150 cases, 55% of cases were estrogen receptor (ER) negative progesterone receptor ( PR) negative. Older women tended to have more steroid receptor reactivity as compared with younger ones. ER positivity decreased with increasing tumor size and grade, however, no significant correlation was seen with lymph node metastasis. Majority of the tumors showing ERPR positivity were infiltrating ductal carcinoma-not otherwise specified type.
CONCLUSION: This study reports a significantly higher incidence of ER negative PR negative phenotype in breast cancer patients. This observation is different as compared with that in western literature where ER positive PR positive phenotype is greater than the negative phenotype suggesting that breast cancer in our patients may have different disease pattern and biology.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15857597     DOI: 04.2005/JCPSP.230233

Source DB:  PubMed          Journal:  J Coll Physicians Surg Pak        ISSN: 1022-386X            Impact factor:   0.711


  6 in total

1.  Correlation of Hormone Receptor Expression with Histologic Parameters in Benign and Malignant Breast Tumors.

Authors:  Deepti Gupta; Veena Gupta; Nisha Marwah; Meenu Gill; Sumiti Gupta; Gopal Gupta; Promil Jain; Rajeev Sen
Journal:  Iran J Pathol       Date:  2015

2.  Blood type, hormone receptor status, HER2/neu status, and survival in breast cancer: a retrospective study exploring relationships in a phenotypically well-defined cohort.

Authors:  Eiko Klimant; Ingrid Glurich; Bickol Mukesh; Adedayo A Onitilo
Journal:  Clin Med Res       Date:  2011-01-24

3.  Profile of breast cancer in a group of women in a developing country in South Asia: is there a difference?

Authors:  Menaka D S Lokuhetty; Gayani G Ranaweera; Manarangi D M Wijeratne; Kumudu H Wickramasinghe; Abdul H Sheriffdeen
Journal:  World J Surg       Date:  2009-03       Impact factor: 3.352

4.  A novel panel of serum miR-21/miR-155/miR-365 as a potential diagnostic biomarker for breast cancer.

Authors:  Ji-Guang Han; Yong-Dong Jiang; Chun-Hui Zhang; Yan-Mei Yang; Da Pang; Yan-Ni Song; Guo-Qiang Zhang
Journal:  Ann Surg Treat Res       Date:  2017-01-31       Impact factor: 1.859

5.  Hormonal and genetic risk factors for breast cancer in a subset of the Karachi population.

Authors:  Fouzia Shaikh; Mohiuddin Alamgir; Sehrish Ahmed
Journal:  J Taibah Univ Med Sci       Date:  2022-02-01

Review 6.  A Review of the Clinical Implications of Breast Cancer Biology.

Authors:  Yekta Parsa; Seyed Abbas Mirmalek; Fatemeh Elham Kani; Amir Aidun; Seyed Alireza Salimi-Tabatabaee; Soheila Yadollah-Damavandi; Ehsan Jangholi; Tina Parsa; Ehsan Shahverdi
Journal:  Electron Physician       Date:  2016-05-25
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.